Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
Clinical trial NCT03870919 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03870919
- Sponsor
- UNICANCER
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-23
- Primary completion
- 2024-08-18
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.